These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9122017)
1. [Subclinical pro-thrombotic state in a relapse of Behcet's disease--case report]. Undas A; Pinis G Pol Arch Med Wewn; 1996 Sep; 96(3):258-62. PubMed ID: 9122017 [TBL] [Abstract][Full Text] [Related]
2. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405 [TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolytic activity in Behçet's disease. Hampton KK; Chamberlain MA; Menon DK; Davies JA Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999 [TBL] [Abstract][Full Text] [Related]
13. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582 [TBL] [Abstract][Full Text] [Related]
14. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154 [TBL] [Abstract][Full Text] [Related]
17. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium. Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous fibrinolytic potential, tPA dependent, is reduced in Behçet's disease. Lotti T; Matucci-Cerinic M Br J Dermatol; 1989 Dec; 121(6):713-6. PubMed ID: 2514783 [TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease. Oztürk MA; Ertenli I; Kiraz S; C Haznedaroğlu I; Celik I; Kirazli S; Calgüneri M Rheumatol Int; 2004 Mar; 24(2):98-102. PubMed ID: 12750940 [TBL] [Abstract][Full Text] [Related]
20. Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease. Kluft C; Michiels JJ; Wijngaards G Scand J Haematol; 1980 Nov; 25(5):423-30. PubMed ID: 6452679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]